Stock SAGENT PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Sagent Pharmaceuticals Inc

Equities

US7866921031

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Sagent Pharmaceuticals Inc
2016 Allergan : Teva, Allergan win U.S. antitrust approval for generics deal RE

Managers

Managers TitleAgeSince
Jeffrey W. Greve DFI
 Director of Finance/CFO 49 31/01/11
Jerry Webb COO
 Chief Operating Officer - 31/12/17
Donald R. Bullock PRN
 Corporate Officer/Principal - 31/12/06

Members of the board

Members of the board TitleAgeSince
Frank Kung BRD
 Director/Board Member 75 30/04/06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,910,475 32,180,075 ( 97.78 %) 0 97.78 %

Company contact information

Sagent Pharmaceuticals, Inc.

1901 North Roselle Road Suite 450

60195, Schaumburg

+

http://www.sagentpharma.com
address Sagent Pharmaceuticals Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+34.35% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.49% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.15% 332B
ABBVIE INC. Stock AbbVie Inc.
+6.19% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.11% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+9.21% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Sagent Pharmaceuticals Inc